Using the cutoff point, HD patients were divided into two groups: Low-FABP4 (HD patients with FABP4 levels below the point) and High-FABP4 (HD patients with FABP4 levels above the cutoff) groups. This evidence concerns the gene FABP4 and Huntington disease.